feed,title,long_url,short_url
Investors,"What To Expect When IBD 50's No. 2, Hims & Hers, Reports Amid The Semaglutide Battle",https://www.investors.com/news/technology/hims-stock-hims-hers-health-earnings-q4-2024/,https://da.gd/KNjtt
